U.S. Oil and Gas Stock News

NasdaqCM:VRDN
NasdaqCM:VRDNBiotechs

Reassessing Viridian Therapeutics (VRDN) After Volatile Share Price Swings

If you are wondering whether Viridian Therapeutics at around US$16.97 is priced for opportunity or risk, the key question is what that tag really says about the business. The stock has recently shown sharp moves, with returns of 25.9% over 7 days and 21.6% over 30 days, while year to date it is down 44.7% and up 32.8% over the past year. This mix of recent gains and earlier weakness has put valuation back in focus as investors reassess what they are willing to pay for Viridian Therapeutics...
NYSE:NOAH
NYSE:NOAHCapital Markets

3 Dividend Stocks To Consider With Up To 21.6% Yield

The market has climbed 3.2% in the last 7 days and is up 31% over the past year, with earnings expected to grow by 16% annually in the coming years. In this environment, dividend stocks that offer substantial yields can be an attractive option for investors seeking income alongside potential growth.